Literature DB >> 31154001

Inhibition of 4E-BP1 phosphorylation promotes tubular cell escaping from G2/M arrest and ameliorates kidney fibrosis.

Xiaoli Sun1, Wei Wei1, Jiafa Ren1, Yan Liang1, Mingjie Wang1, Yuan Gui1, Xian Xue1, Jianzhong Li2, Chunsun Dai3.   

Abstract

Upon occurrence of kidney injury, tubular cells arrested in G2/M stage may promote interstitial fibroblast activation and kidney fibrosis through producing large amounts of pro-fibrotic cytokines. MTORC1 signaling is essential for controlling cell growth, however, the role and mechanisms for mTORC1 in regulating tubular cell cycle progression during kidney fibrosis are not clear. Here we reported that p-S6 abundance was increased at 15 min, reached peak at 1 h and declined from 3 h to 24 h, while the abundance of p-4E-BP1 and p-Histone H3 was increased from 15 min to 24 h in tubular epithelial cells at the similar pattern after serum stimulation. The phosphorylation of 4E-BP1 was prohibited in NRK-52E cells by the transfection of 4E-BP1 plasmid with four phospho-sites mutation (4E-BP1A4). 4E-BP1A4 transfection led to less G2/M cell arrest as well as the production of pro-fibrotic cytokine and extracellular matrix in NRK-52E cells. In addition, aristolochic acid (AA)-induced tubular cell G2/M arrest induced by treatment was also largely attenuated in NRK-52E cells transfected with 4E-BP1A4. In mouse kidneys with UUO nephropathy, p-4E-BP1 abundance was markedly elevated in the mitotic tubular cells. Therefore, these data indicates that suppressing 4E-BP1 phosphorylation may inhibit tubular cell G2/M-arrest and kidney fibrosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4E-BP1; G2/M arrest; Kidney fibrosis; Tubular epithelial cells; mTORC1

Year:  2019        PMID: 31154001     DOI: 10.1016/j.cellsig.2019.05.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.

Authors:  Jing Liu; Yuan Feng; Cheng Sun; Wei Zhu; Qing-Yan Zhang; Bo Jin; Qiu-Yuan Shao; Yang-Yang Xia; Peng-Fei Xu; Miao Zhang; Chun-Ming Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-14

2.  Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus.

Authors:  Shun Nishioka; Takeshi Ishimura; Takahito Endo; Naoki Yokoyama; Satoshi Ogawa; Masato Fujisawa
Journal:  Ann Transplant       Date:  2021-01-12       Impact factor: 1.530

Review 3.  Cell Cycle Dysregulation and Renal Fibrosis.

Authors:  Yun-Shan Wu; Shan Liang; Dong-Yi Li; Jun-Hao Wen; Ji-Xin Tang; Hua-Feng Liu
Journal:  Front Cell Dev Biol       Date:  2021-11-25

4.  Synthesis and Antitumor Evaluation of Menthone-Derived Pyrimidine-Urea Compounds as Potential PI3K/Akt/mTOR Signaling Pathway Inhibitor.

Authors:  Mei Huang; Wengui Duan; Naiyuan Chen; Guishan Lin; Xiu Wang
Journal:  Front Chem       Date:  2022-02-03       Impact factor: 5.221

5.  STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation.

Authors:  Jianzhong Li; Youjing Yang; Qianmin Li; Shuhui Wei; Yujia Zhou; Wangjianfei Yu; Lian Xue; Ling Zhou; Lei Shen; Guoyuan Lu; Ling Chen; Shasha Tao
Journal:  Cell Death Dis       Date:  2022-01-19       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.